Cortechs.ai | A word from the CEO: 2014 in review

A word from the CEO: 2014 in review

2014 was an amazing year at Cortechs.ai. We experienced remarkable growth in all aspects of the company and added many significant hospitals, clinics, universities, imaging service facilities and military bases as customers. I want to warmly thank you for using NeuroQuant in your clinical and research practices.

In my role as the CEO of Cortechs.ai, I get many opportunities to speak with a range of customers – from the neurology and neuroradiology heads of the largest hospitals and clinics, to the smallest imaging services facilities, in the US and in Europe. It is always a great opportunity for me to get a first-hand impression of the state-of-the-art trends in radiology and neurology and to sense the reality and daily challenges of providing imaging healthcare services.

What I have learned this year is that quantitative imaging is getting acceptance in clinical practice and that measuring sub-cortical brain volumes and comparing them to normative values has clinical application in a growing number of clinical disciplines, from dementia, through epilepsy, multiple sclerosis, traumatic brain injuries and a variety of pediatric disorders.

Armed with great customer feedback and with growth momentum, we are getting ready to improve NeuroQuant even further to keep its leading position in the T1-weighted quantitative imaging market. This year NeuroQuant customer will enjoy a much broader set of reports highlighting more brain volumes that are relevant to the above clinical disciplines.  Additionally, we will further improve scan/re-scan accuracy, computational performance and the support of additional platforms such as Windows and Linux.

As usual, we always look for feedback and ideas for improvement and we welcome anybody that wants to share it with us.

I would like to invite you to our website (cortechs.ai) where you will find a wealth of information and scientific publications relevant to quantitative imaging.

Whether you are looking to learn and educate yourself about quantitative neuroimaging, or if you want to hear how to use it in clinical practice – we can help. Feel free to contact us.

Guri Stark
CEO
Cortechs.ai

More Resources

05/04/2025

Introducing NeuroQuant MS Lesion Dynamics Computation: A Clearer Path to Understanding Disease Progression

Discover how the latest NeuroQuant MS update offers a clearer, more intuitive way to track lesion changes and understand disease progression over time.

05/02/2025

4 Reasons Why Over 1500 Medical Centers Worldwide Trust Cortechs.ai

Trusted by 1500+ medical centers, Cortechs.ai delivers AI-powered imaging tools that enhance diagnostic accuracy and streamline workflows.

04/22/2025

Cortechs.ai Receives Health Canada Approval to Expand Sales of AI-Powered Imaging Solutions in North America

Cortechs.ai receives Health Canada approval to expand its AI imaging solutions into Canada, advancing diagnostic precision and patient care.

04/02/2025

Pediatric Neuroimaging Insights: The NeuroQuant® Age Range Series

Brain volumetrics play a pivotal role in understanding pediatric neurological development. Explore how NeuroQuant® enhances neuroimaging from ages 3 to 100.

03/31/2025

How NeuroAlign CT Subtraction Maps Enhance Detection and Confidence in Neuroradiology

What if head CT assessment could be even faster and more accurate? Subtraction maps allow for improved detection and visualization of subtle interval changes.

03/27/2025

Cortechs.ai Joins Forces with Kryptonite Solutions as a Distribution Partner to Expand AI-Driven Neuroimaging Access in India

We are pleased to announce a strategic partnership with Kryptonite Solutions to distribute our innovative portfolio across India.
Scroll to Top